Co-Director of the Neurological Clinical Research Institute (NCRI), Mass General Brigham
Associate Professor of Neurology, Harvard Medical School
Dr. Suma Babu serves as an Associate Professor of Neurology at Harvard Medical School and is the Co-Director of the Neurological Research Institute at Massachusetts General Brigham. Dr. Babu’s research is centered around improving outcomes for people with ALS and therapeutic development for ALS. She has a special interest in early phase clinical trials and gene targeted trials in ALS. Her studies are funded by the NIH, PCORI, Industry or Foundations. Dr. Babu is the PI of the Healey ALS MyMatch Program, launched in 2025, which is a series of patient-centric, multi-site, Phase 1b/2a biomarker-driven clinical trials. She leads the neuroimaging research program for ALS at Mass General Hospital and co-chairs the neuroimaging subcommittee of the international NEALS consortium.
Co-Director of the Neurological Clinical Research Institute (NCRI), Mass General Brigham
Associate Professor of Neurology, Harvard Medical School
Dr. Suma Babu serves as an Associate Professor of Neurology at Harvard Medical School and is the Co-Director of the Neurological Research Institute at Massachusetts General Brigham. Dr. Babu’s research is centered around improving outcomes for people with ALS and therapeutic development for ALS. She has a special interest in early phase clinical trials and gene targeted trials in ALS. Her studies are funded by the NIH, PCORI, Industry or Foundations. Dr. Babu is the PI of the Healey ALS MyMatch Program, launched in 2025, which is a series of patient-centric, multi-site, Phase 1b/2a biomarker-driven clinical trials. She leads the neuroimaging research program for ALS at Mass General Hospital and co-chairs the neuroimaging subcommittee of the international NEALS consortium.